Mary Lanier is a Research Scientist at SRI Biosciences in Menlo Park, CA. Join us to learn how SRI Biosciences is responding to the COVID-19 pandemic—from using existing drug discovery and delivery platforms to innovate vaccines and treatment, to rapid testing capabilities, to developing new vaccines that could protect against future viruses.
Interested in learning more? Register for Mary’s Xtalks on November 18th about using preclinical models to assess vaccines and antivirals: https://bit.ly/3DtxMou
SRI’s The Dish TV highlights the most special part of SRI—our people. Join us for casual conversations with guests from across our institute about what brought them to and keeps them at SRI, as well as the latest world-changing innovations to come out of their groups. At SRI, we’re inventing a better future together.